October 05, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of CareFusion Corporation (NYSE:CFN), was announced concerning whether the takeover of CareFusion by Becton, Dickinson and Co. for a value of $58 per share is unfair to NYSE:CFN stockholders.

The investigation by a law firm concerns whether certain officers and directors of CareFusion Corporation breached their fiduciary duties owed to NYSE:CFN investors in connection with the proposed acquisition.

On October 5, 2014, Becton, Dickinson and Co. (NYSE:BDX) and CareFusion Corporation (NYSE:CFN) announced an agreement under which Becton, Dickinson and Co. will acquire CareFusion Corporation (NYSE:CFN) for $58.00 per share in cash and stock, or a total of $12.2 billion. Under the terms of the transaction, CareFusion Corporation (NYSE:CFN) shareholders will receive $49.00 in cash and 0.0777 of a share of Becton, Dickinson and Co. for each share of CareFusion Corporation (NYSE:CFN), or a total of $58.00 per NYSE:CFN share based on Becton, Dickinson and Cos closing price as of October 3, 2014.

However, the investigation concerns whether the offer is unfair to NYSE:CFN stockholders. More specifically, the investigation concerns whether the CareFusion Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

CareFusion Corporation reported that its Total Revenue rose from $3.55 billion for the 12 months period that ended on June 30, 2013 to over $3.84 billion for the 12 months period that ended on June 30, 2014. Shares of CareFusion Corporation (NYSE:CFN) grew from $22.83 per share in early 2012 to as high as $47.06 per share on September 19, 2014.